» Articles » PMID: 32256212

Circular RNA CircVAPA Knockdown Suppresses Colorectal Cancer Cell Growth Process by Regulating MiR-125a/CREB5 Axis

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2020 Apr 8
PMID 32256212
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Colorectal cancer (CRC) is a malignant tumor, and the overall prognosis of patients with advanced CRC is still unsatisfactory. Circular RNAs (circRNAs) vesicle-associated membrane protein-associated protein A (circVAPA) could act as an underlying biomarker in CRC. This study aimed to explore the mechanism of circVAPA in the regulation of CRC growth.

Methods: CircVAPA level was measured in CRC tumor tissues. The expression levels of circVAPA, VAPA mRNA, microRNA-125a (miR-125a), and cAMP response element binding 5 (CREB5) in CRC cells were detected by RT-qPCR. Cell cycle progression, migration and invasion, extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were measured by flow cytometry, transwell assays and Seahorse XF96 Glycolysis Analyzer, severally. The levels of glucose uptake, lactate and ATP production were examined by Glucose Uptake Colorimetric Assay kit, Lactate Assay kit and ATP Colorimetric Assay kit, respectively. The interaction between miR-125a and circVAPA or CREB5 was predicted by Starbase or DIANA TOOL, and verified by the dual-luciferase reporter and RNA Immunoprecipitation (RIP) assays.

Results: CircVAPA level was up-regulated in CRC tumor tissues. Expression levels of circVAPA and CREB5 were increased, and miR-125a was decreased in CRC cells. CircVAPA knockdown repressed CRC cells cycle progression, migration, invasion and glycolysis. CircVAPA acted as a miR-125a sponge to regulate CREB5 expression. Rescue assay confirmed that miR-125a deletion or CREB5 overexpression weakened the inhibitory effect of circVAPA knockdown on CRC growth.

Conclusion: Our studies disclosed that circVAPA knockdown suppressed CRC cells cycle progression, migration, invasion and glycolysis partly by modulating miR-125a/CREB5 axis, suggesting a potential therapeutic strategy for CRC treatment.

Citing Articles

Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy.

Feng Q, Sun Y, Yang Z, Wang Z, Chen Z, Liu F Front Oncol. 2025; 14():1522919.

PMID: 39850821 PMC: 11754209. DOI: 10.3389/fonc.2024.1522919.


Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas.

Malviya A, Bhuyan R Discov Oncol. 2025; 16(1):5.

PMID: 39755870 PMC: 11700081. DOI: 10.1007/s12672-025-01743-9.


Circular RNA circVAPA mediates alveolar macrophage activation by modulating miR-212-3p/Sirt1 axis in acute respiratory distress syndrome.

Bao L, Li M, Li J, Gao J J Mol Histol. 2024; 56(1):7.

PMID: 39612054 PMC: 11607097. DOI: 10.1007/s10735-024-10312-3.


Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.

Lee Y, Kim W, Park E, Lee D, Kim J, Shin H Int J Mol Sci. 2024; 25(8).

PMID: 38674135 PMC: 11050203. DOI: 10.3390/ijms25084548.


The ATF2/miR-3913-5p/CREB5 axis is involved in the cell proliferation and metastasis of colorectal cancer.

Dai W, Hong L, Xiao W, Zhang L, Sha W, Yu Z Commun Biol. 2023; 6(1):1026.

PMID: 37816820 PMC: 10564889. DOI: 10.1038/s42003-023-05405-w.


References
1.
Dranka B, Benavides G, Diers A, Giordano S, Zelickson B, Reily C . Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med. 2011; 51(9):1621-35. PMC: 3548422. DOI: 10.1016/j.freeradbiomed.2011.08.005. View

2.
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T . CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018; 9(4):417. PMC: 5856798. DOI: 10.1038/s41419-018-0454-8. View

3.
Weng Q, Chen M, Li M, Zheng Y, Shao G, Fan W . Global microarray profiling identified as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. J Med Genet. 2018; 56(1):32-38. DOI: 10.1136/jmedgenet-2018-105440. View

4.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

5.
Xie M, Dart D, Guo T, Xing X, Cheng X, Du H . MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer. 2017; 21(1):41-54. PMC: 5741792. DOI: 10.1007/s10120-017-0721-x. View